PL2780003T3 - Leczenie niedoczynności kory nadnerczy - Google Patents

Leczenie niedoczynności kory nadnerczy

Info

Publication number
PL2780003T3
PL2780003T3 PL12806617T PL12806617T PL2780003T3 PL 2780003 T3 PL2780003 T3 PL 2780003T3 PL 12806617 T PL12806617 T PL 12806617T PL 12806617 T PL12806617 T PL 12806617T PL 2780003 T3 PL2780003 T3 PL 2780003T3
Authority
PL
Poland
Prior art keywords
hyperrasive
cortex
treatment
hyperrasive cortex
Prior art date
Application number
PL12806617T
Other languages
English (en)
Inventor
Hiep Huatan
Richard Ross
Martin Whitaker
Original Assignee
Diurnal Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diurnal Limited filed Critical Diurnal Limited
Publication of PL2780003T3 publication Critical patent/PL2780003T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL12806617T 2011-11-19 2012-11-19 Leczenie niedoczynności kory nadnerczy PL2780003T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1119985.8A GB201119985D0 (en) 2011-11-19 2011-11-19 Treatment of adrenal insufficiency
PCT/GB2012/052864 WO2013072707A1 (en) 2011-11-19 2012-11-19 Treatment of adrenal insufficiency
EP12806617.2A EP2780003B1 (en) 2011-11-19 2012-11-19 Treatment of adrenal insufficiency

Publications (1)

Publication Number Publication Date
PL2780003T3 true PL2780003T3 (pl) 2020-06-29

Family

ID=45475414

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12806617T PL2780003T3 (pl) 2011-11-19 2012-11-19 Leczenie niedoczynności kory nadnerczy

Country Status (22)

Country Link
US (2) US9675559B2 (pl)
EP (1) EP2780003B1 (pl)
JP (2) JP6228125B2 (pl)
KR (1) KR101995999B1 (pl)
AU (1) AU2012338583B2 (pl)
BR (1) BR112014011745B1 (pl)
CA (1) CA2854717C (pl)
CY (1) CY1123130T1 (pl)
DK (1) DK2780003T3 (pl)
ES (1) ES2782503T3 (pl)
GB (2) GB201119985D0 (pl)
HR (1) HRP20200452T1 (pl)
HU (1) HUE048445T2 (pl)
IL (1) IL232065A (pl)
LT (1) LT2780003T (pl)
PL (1) PL2780003T3 (pl)
PT (1) PT2780003T (pl)
RS (1) RS60132B1 (pl)
SI (1) SI2780003T1 (pl)
SM (1) SMT202000230T1 (pl)
WO (1) WO2013072707A1 (pl)
ZA (1) ZA201403462B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition
CN111527096B (zh) 2018-05-14 2023-10-27 株式会社Lg化学 化合物及包含其的有机发光器件
US11904046B1 (en) 2022-11-14 2024-02-20 Eton Pharmaceuticals, Inc. Hydrocortisone oral liquid formulations
WO2025240605A1 (en) 2024-05-15 2025-11-20 Neurocrine Biosciences, Inc. Combination treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2050067C (en) 1990-08-30 2000-05-30 Yasushi Morita Controlled drug release composition
KR19990077278A (ko) 1996-01-16 1999-10-25 마이클 오코넬 약물의 하부 위장관으로의 국소적 전달
DE69721559T2 (de) * 1997-01-06 2003-11-27 Pfizer Inc., New York Geschmacksmaskierte pharmazeutische dosisform mit schneller freisetzung
AU2005235369B2 (en) 2004-04-22 2010-11-11 Acucort Ab Pharmaceutical compositions for acute glucocorticoid therapy
SE0401031D0 (sv) 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
EP1787640A4 (en) 2004-04-30 2012-04-11 Astellas Pharma Inc GRAINED PHARMACEUTICAL COMPOSITION WITH TEMPORARY DELIVERY FOR ORAL ADMINISTRATION AND FAST-DECREASING INTRAORAL TABLET WITH THE COMPOSITION
WO2006026504A2 (en) 2004-08-27 2006-03-09 Spherics, Inc. Mucoadhesive oral formulations of high permeability, high solubility drugs
EP2120868A4 (en) 2007-04-11 2010-08-25 Perrigo Israel Phamaceuticals LOW-DOSED MOMETASON FORMULATIONS
JP5461179B2 (ja) * 2007-06-06 2014-04-02 旭化成ケミカルズ株式会社 セルロース系微小核粒子及びその製造方法
GB0817120D0 (en) 2008-09-19 2008-10-29 Diurnal Ltd Treatment of adrenal insufficiency
NZ602010A (en) 2009-04-07 2013-11-29 Duocort Pharma Ab Improved glucocorticoid therapy
WO2011032916A1 (de) * 2009-09-17 2011-03-24 Basf Se Mit wirkstoffhaltigen überzügen beschichtete pellets
CN102933218A (zh) 2010-05-20 2013-02-13 杜奥科特药物公司 糖皮质激素基的组合物的剂量学和施用
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition

Also Published As

Publication number Publication date
GB201407380D0 (en) 2014-06-11
CA2854717A1 (en) 2013-05-23
RS60132B1 (sr) 2020-05-29
IL232065A (en) 2016-04-21
GB2509663B (en) 2015-01-07
EP2780003B1 (en) 2020-02-19
SI2780003T1 (sl) 2020-07-31
IL232065A0 (en) 2014-05-28
US9717740B1 (en) 2017-08-01
US20170202856A1 (en) 2017-07-20
HK1194005A1 (en) 2014-10-10
ES2782503T3 (es) 2020-09-15
PT2780003T (pt) 2020-04-08
KR20140108638A (ko) 2014-09-12
HUE048445T2 (hu) 2020-08-28
BR112014011745B1 (pt) 2022-04-05
JP2017200942A (ja) 2017-11-09
CY1123130T1 (el) 2021-10-29
LT2780003T (lt) 2020-04-27
AU2012338583A1 (en) 2014-05-01
CA2854717C (en) 2020-12-08
KR101995999B1 (ko) 2019-07-03
BR112014011745A2 (pt) 2017-05-30
AU2012338583B2 (en) 2017-01-19
JP6228125B2 (ja) 2017-11-08
JP2014533679A (ja) 2014-12-15
HRP20200452T1 (hr) 2020-10-16
WO2013072707A1 (en) 2013-05-23
ZA201403462B (en) 2016-05-25
SMT202000230T1 (it) 2020-07-08
EP2780003A1 (en) 2014-09-24
US20140287052A1 (en) 2014-09-25
GB2509663A (en) 2014-07-09
DK2780003T3 (da) 2020-03-30
GB201119985D0 (en) 2012-01-04
US9675559B2 (en) 2017-06-13

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
LT2885010T (lt) Tautopatijos gydymo būdai
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
EP2670434A4 (en) TREATMENT OF TAUOPATHIES
HUE048876T2 (hu) Rákos megbetegedések kezelése
PL2739153T3 (pl) Leczenie raka sutka
PT2766014T (pt) Métodos de tratar pacientes pediátricos utilizando dexmedetomidina
EP2740419A4 (en) TREATMENT INSTRUMENT
HUE053247T2 (hu) Mieloszuppresszió kezelése
EP2819703A4 (en) PAIN TREATMENT
PL3251666T3 (pl) Sposób leczenia urazu neurologicznego
SMT201600129B (it) Trattamento della lipodistrofia
HRP20180237T1 (hr) Metode za liječenje hcv-a
EP2906208A4 (en) THERAPEUTIC TREATMENT
DK2717941T3 (da) Behandling af cancer
BR112014007029A2 (pt) métodos aperfeiçoados de terapia gênica
IL231092A0 (en) Treatment of rhinitis
EP2750709A4 (en) TREATMENT OF KACHEXIE
BR112013022820A2 (pt) método de tratamento
PL2776055T3 (pl) Sposoby leczenia zaburzeń żołądkowo-jelitowych
BR112013023142A2 (pt) método de tratamento de cabelos
PL2718434T3 (pl) Kompozycje i sposoby leczenia choroby trzewnej
EP2709665A4 (en) TREATMENT OF PSORIASIS
HRP20181000T1 (hr) Postupci liječenja stanja povezanih s kosom
PL3536410T3 (pl) Metoda przetwarzania odpadów